According to a study in the New England Journal of Medicine, Retatrutides formulation was designed for once-weekly subcutaneous injection models for patients to evaluate long-term effects on energy balance and metabolism
Castellana M, Cignarelli A, Brescia F, Laviola L, Giorgino F (2019) GLP-1 receptor agonist added to insulin versus basal-plus or basal-bolus insulin therapy in type 2 diabetes: a systematic review and meta-analysis
Some arent even waiting for approval from the Food and Drug Administration, instead racing to acquire it through sketchy means
Although manufacturer savings cards and patient assistance programs may reduce costs for some commercially insured patients, these programs often exclude Medicare and Medicaid beneficiaries and frequently contain annual savings caps or eligibility limitations
The Bridge runs July 1, 2026 through December 31, 2027
As for long-term use, these medications are generally well-tolerated for extended periods